Loading InvisibleSignal...

Demographics Dashboard

Long COVID prevalence disparities from Census Household Pulse Survey

Overall Prevalence: 7.5%
Highest Demographic: 15%
Highest State: 12.7%
Activity Limitation: 25%

Gender Comparison

Long COVID prevalence by gender identity

Women are 1.7x more likely to experience Long COVID than men. Female prevalence: 9.4%, Male prevalence: 5.5%.

Age Group Distribution

Prevalence peaks at ages 50–59 then declines

Working-age adults (40–59) bear the highest burden, with significant workforce impact. Peak prevalence: 9.3% at ages 50–59.

Race/Ethnicity Comparison

Disparities across racial and ethnic groups

Hispanic Americans face the highest racial/ethnic prevalence at 9.0%, 2.4x the rate of Asian Americans (3.7%). White: 7.5%, Black: 6.8%.

Sexual/Gender Identity

Transgender individuals face 2x the national average

The transgender community faces the highest Long COVID prevalence of any demographic group at 15.0%, more than double the national average of 7.5%. Bisexual: 12.0%, Cisgender LGB: 9.0%, Cisgender Straight: 7.0%.

State Hotspots (Top 5)

States with highest Long COVID prevalence rates

Southern and Appalachian states dominate. Top 5: Kentucky 12.7%, Alabama 12.1%, Tennessee 11.6%, South Dakota 11.6%, West Virginia 11.3%. These regions also have higher rates of chronic disease comorbidities and fewer specialty providers.

Cross-Condition Comparison

Prevalence and diagnostic delay across all tracked conditions

Total Affected Americans: 36.8M
Avg Diagnostic Delay: 4.1 yrs
Worst Female Disparity: 80%

Estimated US Prevalence

Total affected individuals per condition

Long COVID dominates at 18M affected, but ME/CFS and Fibromyalgia together affect over 13M Americans.

Diagnostic Delay Comparison

Average years from symptom onset to diagnosis

Alpha-gal Syndrome has the worst diagnostic delay at 7 years, followed by Fibromyalgia at 5 years. Lyme Disease: 4.4 years, ME/CFS: 4 years, POTS: 4 years, Long COVID: 0.5 years. These delays contribute to patient suffering and increased healthcare costs.

Source: U.S. Census Bureau Household Pulse Survey (2022–2024). Data reflects self-reported Long COVID status among U.S. adults aged 18+. Prevalence estimates may vary by survey wave. See Census HPS data portal for full methodology.

Explore Related Modules

Pattern Engine

Cross-condition analysis

Health Equity

SDOH and access gaps

Surveillance Map

Interactive Lyme disease choropleth

Cost Calculator

Per-patient cost estimates

Data Sources (3)

U.S. Census Bureau. Household Pulse Survey (HPS). 2022-2024.
Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS). 2018-2022.
National Institutes of Health. Researching COVID to Enhance Recovery (RECOVER). 2023.